APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cardiac AI-assisted Diagnosis Software

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cardiac AI-assisted Diagnosis Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

6 March 2026191 pages

Choose your research edition.

Industry ResearchCardiac AI-assisted Diagnosis Software Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiac AI-assisted Diagnosis Software Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Cardiac AI-assisted Diagnosis Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiac AI-assisted Diagnosis Software Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiac AI-assisted Diagnosis Software Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Cardiac AI-assisted Diagnosis Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Cardiac AI-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cardiac AI-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cardiac AI-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cardiac AI-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cardiac AI-assisted Diagnosis Software include Lepu Medical, G K Healthcare, Sense Time, United Imaging, Infervision, Shukun, FOSUN AITROX, NANO-X and MyCardium AI, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Cardiac AI-assisted Diagnosis Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cardiac AI-assisted Diagnosis Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cardiac AI-assisted Diagnosis Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Cardiac AI-assisted Diagnosis Software market size, projected growth trends, production technologies, key applications, and end-use industries.

Cardiac AI-assisted Diagnosis Software Segment by Company

Lepu Medical

G K Healthcare

Sense Time

United Imaging

Infervision

Shukun

FOSUN AITROX

NANO-X

MyCardium AI

VUNO

Caption Care

UltraSight

Ultromics

Cleerly

Elucid

DiA Imaging Analysis

Koninklijke Philips N.V

Fujifilm

Cardiac AI-assisted Diagnosis Software Segment by Type

Cloud-based

On-Primes

Cardiac AI-assisted Diagnosis Software Segment by Application

Hospital

Clinic

Imaging Center

Cardiac AI-assisted Diagnosis Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiac AI-assisted Diagnosis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiac AI-assisted Diagnosis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiac AI-assisted Diagnosis Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cardiac AI-assisted Diagnosis Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cardiac AI-assisted Diagnosis Software industry.

Chapter 3: Detailed analysis of Cardiac AI-assisted Diagnosis Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cardiac AI-assisted Diagnosis Softwarerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cardiac AI-assisted Diagnosis Software Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Cloud-based Table 3. Key Players of On-Primes Table 4. Global Cardiac AI-assisted Diagnosis Software Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Key Players of Imaging Center Table 8. Global Cardiac AI-assisted Diagnosis Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Cardiac AI-assisted Diagnosis Software Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Cardiac AI-assisted Diagnosis Software Market Share by Region (2021-2026) Table 11. Global Cardiac AI-assisted Diagnosis Software Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Cardiac AI-assisted Diagnosis Software Market Share by Region (2027-2032) Table 13. Cardiac AI-assisted Diagnosis Software Industry Trends Table 14. Cardiac AI-assisted Diagnosis Software Industry Drivers Table 15. Cardiac AI-assisted Diagnosis Software Industry Opportunities and Challenges Table 16. Cardiac AI-assisted Diagnosis Software Industry Restraints Table 17. Global Cardiac AI-assisted Diagnosis Software Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Cardiac AI-assisted Diagnosis Software Revenue Market Share by Company (2021-2026) Table 19. Global Cardiac AI-assisted Diagnosis Software Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Cardiac AI-assisted Diagnosis Software Key Company Head Office and Area Served Table 21. Global Cardiac AI-assisted Diagnosis Software Company, Product Type & Application Table 22. Global Cardiac AI-assisted Diagnosis Software Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Cardiac AI-assisted Diagnosis Software by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Cardiac AI-assisted Diagnosis Software Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Cardiac AI-assisted Diagnosis Software Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Cardiac AI-assisted Diagnosis Software Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Cardiac AI-assisted Diagnosis Software Revenue Market Share by Type (2021-2026) Table 29. Global Cardiac AI-assisted Diagnosis Software Revenue Market Share by Type (2027-2032) Table 30. Global Cardiac AI-assisted Diagnosis Software Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Cardiac AI-assisted Diagnosis Software Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Cardiac AI-assisted Diagnosis Software Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Cardiac AI-assisted Diagnosis Software Revenue Market Share by Application (2021-2026) Table 34. Global Cardiac AI-assisted Diagnosis Software Revenue Market Share by Application (2027-2032) Table 35. Lepu Medical Company Information Table 36. Lepu Medical Business Overview Table 37. Lepu Medical Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Lepu Medical Cardiac AI-assisted Diagnosis Software Product Portfolio Table 39. Lepu Medical Recent Development Table 40. G K Healthcare Company Information Table 41. G K Healthcare Business Overview Table 42. G K Healthcare Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. G K Healthcare Cardiac AI-assisted Diagnosis Software Product Portfolio Table 44. G K Healthcare Recent Development Table 45. Sense Time Company Information Table 46. Sense Time Business Overview Table 47. Sense Time Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Sense Time Cardiac AI-assisted Diagnosis Software Product Portfolio Table 49. Sense Time Recent Development Table 50. United Imaging Company Information Table 51. United Imaging Business Overview Table 52. United Imaging Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. United Imaging Cardiac AI-assisted Diagnosis Software Product Portfolio Table 54. United Imaging Recent Development Table 55. Infervision Company Information Table 56. Infervision Business Overview Table 57. Infervision Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Infervision Cardiac AI-assisted Diagnosis Software Product Portfolio Table 59. Infervision Recent Development Table 60. Shukun Company Information Table 61. Shukun Business Overview Table 62. Shukun Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Shukun Cardiac AI-assisted Diagnosis Software Product Portfolio Table 64. Shukun Recent Development Table 65. FOSUN AITROX Company Information Table 66. FOSUN AITROX Business Overview Table 67. FOSUN AITROX Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. FOSUN AITROX Cardiac AI-assisted Diagnosis Software Product Portfolio Table 69. FOSUN AITROX Recent Development Table 70. NANO-X Company Information Table 71. NANO-X Business Overview Table 72. NANO-X Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. NANO-X Cardiac AI-assisted Diagnosis Software Product Portfolio Table 74. NANO-X Recent Development Table 75. MyCardium AI Company Information Table 76. MyCardium AI Business Overview Table 77. MyCardium AI Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. MyCardium AI Cardiac AI-assisted Diagnosis Software Product Portfolio Table 79. MyCardium AI Recent Development Table 80. VUNO Company Information Table 81. VUNO Business Overview Table 82. VUNO Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. VUNO Cardiac AI-assisted Diagnosis Software Product Portfolio Table 84. VUNO Recent Development Table 85. Caption Care Company Information Table 86. Caption Care Business Overview Table 87. Caption Care Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Caption Care Cardiac AI-assisted Diagnosis Software Product Portfolio Table 89. Caption Care Recent Development Table 90. UltraSight Company Information Table 91. UltraSight Business Overview Table 92. UltraSight Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. UltraSight Cardiac AI-assisted Diagnosis Software Product Portfolio Table 94. UltraSight Recent Development Table 95. Ultromics Company Information Table 96. Ultromics Business Overview Table 97. Ultromics Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Ultromics Cardiac AI-assisted Diagnosis Software Product Portfolio Table 99. Ultromics Recent Development Table 100. Cleerly Company Information Table 101. Cleerly Business Overview Table 102. Cleerly Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Cleerly Cardiac AI-assisted Diagnosis Software Product Portfolio Table 104. Cleerly Recent Development Table 105. Elucid Company Information Table 106. Elucid Business Overview Table 107. Elucid Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Elucid Cardiac AI-assisted Diagnosis Software Product Portfolio Table 109. Elucid Recent Development Table 110. DiA Imaging Analysis Company Information Table 111. DiA Imaging Analysis Business Overview Table 112. DiA Imaging Analysis Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. DiA Imaging Analysis Cardiac AI-assisted Diagnosis Software Product Portfolio Table 114. DiA Imaging Analysis Recent Development Table 115. Koninklijke Philips N.V Company Information Table 116. Koninklijke Philips N.V Business Overview Table 117. Koninklijke Philips N.V Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Koninklijke Philips N.V Cardiac AI-assisted Diagnosis Software Product Portfolio Table 119. Koninklijke Philips N.V Recent Development Table 120. Fujifilm Company Information Table 121. Fujifilm Business Overview Table 122. Fujifilm Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. Fujifilm Cardiac AI-assisted Diagnosis Software Product Portfolio Table 124. Fujifilm Recent Development Table 125. North America Cardiac AI-assisted Diagnosis Software Market Size by Type (2021-2026) & (US$ Million) Table 126. North America Cardiac AI-assisted Diagnosis Software Market Size by Type (2027-2032) & (US$ Million) Table 127. North America Cardiac AI-assisted Diagnosis Software Market Size by Application (2021-2026) & (US$ Million) Table 128. North America Cardiac AI-assisted Diagnosis Software Market Size by Application (2027-2032) & (US$ Million) Table 129. North America Cardiac AI-assisted Diagnosis Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Cardiac AI-assisted Diagnosis Software Market Size by Country (2021-2026) Table 131. North America Cardiac AI-assisted Diagnosis Software Market Size by Country (2027-2032) Table 132. Europe Cardiac AI-assisted Diagnosis Software Market Size by Type (2021-2026) & (US$ Million) Table 133. Europe Cardiac AI-assisted Diagnosis Software Market Size by Type (2027-2032) & (US$ Million) Table 134. Europe Cardiac AI-assisted Diagnosis Software Market Size by Application (2021-2026) & (US$ Million) Table 135. Europe Cardiac AI-assisted Diagnosis Software Market Size by Application (2027-2032) & (US$ Million) Table 136. Europe Cardiac AI-assisted Diagnosis Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Cardiac AI-assisted Diagnosis Software Market Size by Country (2021-2026) Table 138. Europe Cardiac AI-assisted Diagnosis Software Market Size by Country (2027-2032) Table 139. China Cardiac AI-assisted Diagnosis Software Market Size by Type (2021-2026) & (US$ Million) Table 140. China Cardiac AI-assisted Diagnosis Software Market Size by Type (2027-2032) & (US$ Million) Table 141. China Cardiac AI-assisted Diagnosis Software Market Size by Application (2021-2026) & (US$ Million) Table 142. China Cardiac AI-assisted Diagnosis Software Market Size by Application (2027-2032) & (US$ Million) Table 143. Asia Cardiac AI-assisted Diagnosis Software Market Size by Type (2021-2026) & (US$ Million) Table 144. Asia Cardiac AI-assisted Diagnosis Software Market Size by Type (2027-2032) & (US$ Million) Table 145. Asia Cardiac AI-assisted Diagnosis Software Market Size by Application (2021-2026) & (US$ Million) Table 146. Asia Cardiac AI-assisted Diagnosis Software Market Size by Application (2027-2032) & (US$ Million) Table 147. Asia Cardiac AI-assisted Diagnosis Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia Cardiac AI-assisted Diagnosis Software Market Size by Country (2021-2026) Table 149. Asia Cardiac AI-assisted Diagnosis Software Market Size by Country (2027-2032) Table 150. South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Size by Type (2021-2026) & (US$ Million) Table 151. South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Size by Type (2027-2032) & (US$ Million) Table 152. South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Size by Application (2021-2026) & (US$ Million) Table 153. South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Size by Application (2027-2032) & (US$ Million) Table 154. South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Size by Country (2021-2026) Table 156. South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Size by Country (2027-2032) Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Cardiac AI-assisted Diagnosis Software Product Image Figure 2. Global Cardiac AI-assisted Diagnosis Software Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Cardiac AI-assisted Diagnosis Software Market Share by Type: 2025 VS 2032 Figure 4. Cloud-based Image Figure 5. On-Primes Image Figure 6. Global Cardiac AI-assisted Diagnosis Software Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Cardiac AI-assisted Diagnosis Software Market Share by Application: 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Imaging Center Image Figure 11. Global Cardiac AI-assisted Diagnosis Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 13. Global Cardiac AI-assisted Diagnosis Software Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Cardiac AI-assisted Diagnosis Software Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Cardiac AI-assisted Diagnosis Software Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Cardiac AI-assisted Diagnosis Software Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Cardiac AI-assisted Diagnosis Software Revenue Market Share by Type (2021-2032) Figure 20. Global Cardiac AI-assisted Diagnosis Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Cardiac AI-assisted Diagnosis Software Revenue Market Share by Application (2021-2032) Figure 22. North America Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 23. North America Cardiac AI-assisted Diagnosis Software Market Share by Type (2021-2032) Figure 24. North America Cardiac AI-assisted Diagnosis Software Market Share by Application (2021-2032) Figure 25. North America Cardiac AI-assisted Diagnosis Software Market Share by Country (2021-2032) Figure 26. United States Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 27. Canada Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 29. Europe Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 30. Europe Cardiac AI-assisted Diagnosis Software Market Share by Type (2021-2032) Figure 31. Europe Cardiac AI-assisted Diagnosis Software Market Share by Application (2021-2032) Figure 32. Europe Cardiac AI-assisted Diagnosis Software Market Share by Country (2021-2032) Figure 33. Germany Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 34. France Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 36. Italy Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 37. Russia Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 39. China Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 40. China Cardiac AI-assisted Diagnosis Software Market Share by Type (2021-2032) Figure 41. China Cardiac AI-assisted Diagnosis Software Market Share by Application (2021-2032) Figure 42. Asia Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 43. Asia Cardiac AI-assisted Diagnosis Software Market Share by Type (2021-2032) Figure 44. Asia Cardiac AI-assisted Diagnosis Software Market Share by Application (2021-2032) Figure 45. Asia Cardiac AI-assisted Diagnosis Software Market Share by Country (2021-2032) Figure 46. Japan Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 50. India Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 51. Australia Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Share by Country (2021-2032) Figure 56. Brazil Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 61. UAE Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 63. Chile Cardiac AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-Primes
Applications
  • Hospital
  • Clinic
  • Imaging Center
Companies covered
  • Lepu Medical
  • G K Healthcare
  • Sense Time
  • United Imaging
  • Infervision
  • Shukun
  • FOSUN AITROX
  • NANO-X
  • MyCardium AI
  • VUNO
  • Caption Care
  • UltraSight
  • Ultromics
  • Cleerly
  • Elucid
  • DiA Imaging Analysis
  • Koninklijke Philips N.V
  • Fujifilm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Cardiac AI-assisted Diagnosis Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-based
  5. 1.2.3 On-Primes
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Cardiac AI-assisted Diagnosis Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Imaging Center
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Cardiac AI-assisted Diagnosis Software Growth Trends by Region
  13. 1.5.1 Global Cardiac AI-assisted Diagnosis Software Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Cardiac AI-assisted Diagnosis Software Market Size by Region (2021-2026)
  15. 1.5.3 Cardiac AI-assisted Diagnosis Software Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Cardiac AI-assisted Diagnosis Software Market Dynamics
  1. 2.1 Cardiac AI-assisted Diagnosis Software Industry Trends
  2. 2.2 Cardiac AI-assisted Diagnosis Software Industry Drivers
  3. 2.3 Cardiac AI-assisted Diagnosis Software Industry Opportunities and Challenges
  4. 2.4 Cardiac AI-assisted Diagnosis Software Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Cardiac AI-assisted Diagnosis Software Revenue by Company (2021-2026)
  2. 3.2 Global Cardiac AI-assisted Diagnosis Software Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Cardiac AI-assisted Diagnosis Software Key Company Head office and Area Served
  4. 3.4 Global Cardiac AI-assisted Diagnosis Software Company, Product Type & Application
  5. 3.5 Global Cardiac AI-assisted Diagnosis Software Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Cardiac AI-assisted Diagnosis Software Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Cardiac AI-assisted Diagnosis Software Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Cardiac AI-assisted Diagnosis Software Tier 1, Tier 2, and Tier 3
4 Cardiac AI-assisted Diagnosis Software Market by Type
  1. 4.1 Global Cardiac AI-assisted Diagnosis Software Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Cardiac AI-assisted Diagnosis Software Market Size by Type (2021-2032)
  3. 4.3 Global Cardiac AI-assisted Diagnosis Software Market Size Share by Type (2021-2032)
5 Cardiac AI-assisted Diagnosis Software Market by Application
  1. 5.1 Global Cardiac AI-assisted Diagnosis Software Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Cardiac AI-assisted Diagnosis Software Market Size by Application (2021-2032)
  3. 5.3 Global Cardiac AI-assisted Diagnosis Software Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Lepu Medical
  2. 6.1.1 Lepu Medical Company Information
  3. 6.1.2 Lepu Medical Business Overview
  4. 6.1.3 Lepu Medical Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Lepu Medical Cardiac AI-assisted Diagnosis Software Product Portfolio
  6. 6.1.5 Lepu Medical Recent Developments
  7. 6.2 G K Healthcare
  8. 6.2.1 G K Healthcare Company Information
  9. 6.2.2 G K Healthcare Business Overview
  10. 6.2.3 G K Healthcare Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 G K Healthcare Cardiac AI-assisted Diagnosis Software Product Portfolio
  12. 6.2.5 G K Healthcare Recent Developments
  13. 6.3 Sense Time
  14. 6.3.1 Sense Time Company Information
  15. 6.3.2 Sense Time Business Overview
  16. 6.3.3 Sense Time Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Sense Time Cardiac AI-assisted Diagnosis Software Product Portfolio
  18. 6.3.5 Sense Time Recent Developments
  19. 6.4 United Imaging
  20. 6.4.1 United Imaging Company Information
  21. 6.4.2 United Imaging Business Overview
  22. 6.4.3 United Imaging Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 United Imaging Cardiac AI-assisted Diagnosis Software Product Portfolio
  24. 6.4.5 United Imaging Recent Developments
  25. 6.5 Infervision
  26. 6.5.1 Infervision Company Information
  27. 6.5.2 Infervision Business Overview
  28. 6.5.3 Infervision Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Infervision Cardiac AI-assisted Diagnosis Software Product Portfolio
  30. 6.5.5 Infervision Recent Developments
  31. 6.6 Shukun
  32. 6.6.1 Shukun Company Information
  33. 6.6.2 Shukun Business Overview
  34. 6.6.3 Shukun Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Shukun Cardiac AI-assisted Diagnosis Software Product Portfolio
  36. 6.6.5 Shukun Recent Developments
  37. 6.7 FOSUN AITROX
  38. 6.7.1 FOSUN AITROX Company Information
  39. 6.7.2 FOSUN AITROX Business Overview
  40. 6.7.3 FOSUN AITROX Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 FOSUN AITROX Cardiac AI-assisted Diagnosis Software Product Portfolio
  42. 6.7.5 FOSUN AITROX Recent Developments
  43. 6.8 NANO-X
  44. 6.8.1 NANO-X Company Information
  45. 6.8.2 NANO-X Business Overview
  46. 6.8.3 NANO-X Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 NANO-X Cardiac AI-assisted Diagnosis Software Product Portfolio
  48. 6.8.5 NANO-X Recent Developments
  49. 6.9 MyCardium AI
  50. 6.9.1 MyCardium AI Company Information
  51. 6.9.2 MyCardium AI Business Overview
  52. 6.9.3 MyCardium AI Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 MyCardium AI Cardiac AI-assisted Diagnosis Software Product Portfolio
  54. 6.9.5 MyCardium AI Recent Developments
  55. 6.10 VUNO
  56. 6.10.1 VUNO Company Information
  57. 6.10.2 VUNO Business Overview
  58. 6.10.3 VUNO Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 VUNO Cardiac AI-assisted Diagnosis Software Product Portfolio
  60. 6.10.5 VUNO Recent Developments
  61. 6.11 Caption Care
  62. 6.11.1 Caption Care Company Information
  63. 6.11.2 Caption Care Business Overview
  64. 6.11.3 Caption Care Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Caption Care Cardiac AI-assisted Diagnosis Software Product Portfolio
  66. 6.11.5 Caption Care Recent Developments
  67. 6.12 UltraSight
  68. 6.12.1 UltraSight Company Information
  69. 6.12.2 UltraSight Business Overview
  70. 6.12.3 UltraSight Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 UltraSight Cardiac AI-assisted Diagnosis Software Product Portfolio
  72. 6.12.5 UltraSight Recent Developments
  73. 6.13 Ultromics
  74. 6.13.1 Ultromics Company Information
  75. 6.13.2 Ultromics Business Overview
  76. 6.13.3 Ultromics Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Ultromics Cardiac AI-assisted Diagnosis Software Product Portfolio
  78. 6.13.5 Ultromics Recent Developments
  79. 6.14 Cleerly
  80. 6.14.1 Cleerly Company Information
  81. 6.14.2 Cleerly Business Overview
  82. 6.14.3 Cleerly Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Cleerly Cardiac AI-assisted Diagnosis Software Product Portfolio
  84. 6.14.5 Cleerly Recent Developments
  85. 6.15 Elucid
  86. 6.15.1 Elucid Company Information
  87. 6.15.2 Elucid Business Overview
  88. 6.15.3 Elucid Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Elucid Cardiac AI-assisted Diagnosis Software Product Portfolio
  90. 6.15.5 Elucid Recent Developments
  91. 6.16 DiA Imaging Analysis
  92. 6.16.1 DiA Imaging Analysis Company Information
  93. 6.16.2 DiA Imaging Analysis Business Overview
  94. 6.16.3 DiA Imaging Analysis Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 DiA Imaging Analysis Cardiac AI-assisted Diagnosis Software Product Portfolio
  96. 6.16.5 DiA Imaging Analysis Recent Developments
  97. 6.17 Koninklijke Philips N.V
  98. 6.17.1 Koninklijke Philips N.V Company Information
  99. 6.17.2 Koninklijke Philips N.V Business Overview
  100. 6.17.3 Koninklijke Philips N.V Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Koninklijke Philips N.V Cardiac AI-assisted Diagnosis Software Product Portfolio
  102. 6.17.5 Koninklijke Philips N.V Recent Developments
  103. 6.18 Fujifilm
  104. 6.18.1 Fujifilm Company Information
  105. 6.18.2 Fujifilm Business Overview
  106. 6.18.3 Fujifilm Cardiac AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Fujifilm Cardiac AI-assisted Diagnosis Software Product Portfolio
  108. 6.18.5 Fujifilm Recent Developments
7 North America
  1. 7.1 North America Cardiac AI-assisted Diagnosis Software Market Size (2021-2032)
  2. 7.2 North America Cardiac AI-assisted Diagnosis Software Market Size by Type
  3. 7.2.1 North America Cardiac AI-assisted Diagnosis Software Market Size by Type (2021-2026)
  4. 7.2.2 North America Cardiac AI-assisted Diagnosis Software Market Size by Type (2027-2032)
  5. 7.2.3 North America Cardiac AI-assisted Diagnosis Software Market Share by Type (2021-2032)
  6. 7.3 North America Cardiac AI-assisted Diagnosis Software Market Size by Application
  7. 7.3.1 North America Cardiac AI-assisted Diagnosis Software Market Size by Application (2021-2026)
  8. 7.3.2 North America Cardiac AI-assisted Diagnosis Software Market Size by Application (2027-2032)
  9. 7.3.3 North America Cardiac AI-assisted Diagnosis Software Market Share by Application (2021-2032)
  10. 7.4 North America Cardiac AI-assisted Diagnosis Software Market Size by Country
  11. 7.4.1 North America Cardiac AI-assisted Diagnosis Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Cardiac AI-assisted Diagnosis Software Market Size by Country (2021-2026)
  13. 7.4.3 North America Cardiac AI-assisted Diagnosis Software Market Size by Country (2027-2032)
  14. 7.4.4 North America Cardiac AI-assisted Diagnosis Software Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Cardiac AI-assisted Diagnosis Software Market Size (2021-2032)
  2. 8.2 Europe Cardiac AI-assisted Diagnosis Software Market Size by Type
  3. 8.2.1 Europe Cardiac AI-assisted Diagnosis Software Market Size by Type (2021-2026)
  4. 8.2.2 Europe Cardiac AI-assisted Diagnosis Software Market Size by Type (2027-2032)
  5. 8.2.3 Europe Cardiac AI-assisted Diagnosis Software Market Share by Type (2021-2032)
  6. 8.3 Europe Cardiac AI-assisted Diagnosis Software Market Size by Application
  7. 8.3.1 Europe Cardiac AI-assisted Diagnosis Software Market Size by Application (2021-2026)
  8. 8.3.2 Europe Cardiac AI-assisted Diagnosis Software Market Size by Application (2027-2032)
  9. 8.3.3 Europe Cardiac AI-assisted Diagnosis Software Market Share by Application (2021-2032)
  10. 8.4 Europe Cardiac AI-assisted Diagnosis Software Market Size by Country
  11. 8.4.1 Europe Cardiac AI-assisted Diagnosis Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Cardiac AI-assisted Diagnosis Software Market Size by Country (2021-2026)
  13. 8.4.3 Europe Cardiac AI-assisted Diagnosis Software Market Size by Country (2027-2032)
  14. 8.4.4 Europe Cardiac AI-assisted Diagnosis Software Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Cardiac AI-assisted Diagnosis Software Market Size (2021-2032)
  2. 9.2 China Cardiac AI-assisted Diagnosis Software Market Size by Type
  3. 9.2.1 China Cardiac AI-assisted Diagnosis Software Market Size by Type (2021-2026)
  4. 9.2.2 China Cardiac AI-assisted Diagnosis Software Market Size by Type (2027-2032)
  5. 9.2.3 China Cardiac AI-assisted Diagnosis Software Market Share by Type (2021-2032)
  6. 9.3 China Cardiac AI-assisted Diagnosis Software Market Size by Application
  7. 9.3.1 China Cardiac AI-assisted Diagnosis Software Market Size by Application (2021-2026)
  8. 9.3.2 China Cardiac AI-assisted Diagnosis Software Market Size by Application (2027-2032)
  9. 9.3.3 China Cardiac AI-assisted Diagnosis Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Cardiac AI-assisted Diagnosis Software Market Size (2021-2032)
  2. 10.2 Asia Cardiac AI-assisted Diagnosis Software Market Size by Type
  3. 10.2.1 Asia Cardiac AI-assisted Diagnosis Software Market Size by Type (2021-2026)
  4. 10.2.2 Asia Cardiac AI-assisted Diagnosis Software Market Size by Type (2027-2032)
  5. 10.2.3 Asia Cardiac AI-assisted Diagnosis Software Market Share by Type (2021-2032)
  6. 10.3 Asia Cardiac AI-assisted Diagnosis Software Market Size by Application
  7. 10.3.1 Asia Cardiac AI-assisted Diagnosis Software Market Size by Application (2021-2026)
  8. 10.3.2 Asia Cardiac AI-assisted Diagnosis Software Market Size by Application (2027-2032)
  9. 10.3.3 Asia Cardiac AI-assisted Diagnosis Software Market Share by Application (2021-2032)
  10. 10.4 Asia Cardiac AI-assisted Diagnosis Software Market Size by Country
  11. 10.4.1 Asia Cardiac AI-assisted Diagnosis Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Cardiac AI-assisted Diagnosis Software Market Size by Country (2021-2026)
  13. 10.4.3 Asia Cardiac AI-assisted Diagnosis Software Market Size by Country (2027-2032)
  14. 10.4.4 Asia Cardiac AI-assisted Diagnosis Software Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Cardiac AI-assisted Diagnosis Software Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst